Successful treatment of primary donor-derived human herpesvirus-8 infection and hepatic Kaposi Sarcoma in an adult liver transplant recipient

Transpl Infect Dis. 2018 Oct;20(5):e12966. doi: 10.1111/tid.12966. Epub 2018 Aug 23.

Abstract

Kaposi sarcoma (KS) may rarely occur in transplant recipients through primary human herpesvirus-8 (HHV-8) infection from a seropositive donor. This report describes a patient who developed hepatic KS after receiving a split liver transplant from an HHV-8-positive donor. The recipient was treated with liposomal doxorubicin after reduction in immunosuppression led to acute cellular rejection. This treatment achieved regression of KS while preserving allograft function, demonstrating a successful therapeutic strategy for this malignancy.

Keywords: human herpesvirus-8; liver transplant; post-transplant Kaposi Sarcoma.

Publication types

  • Case Reports

MeSH terms

  • Allografts / diagnostic imaging
  • Allografts / pathology
  • Allografts / virology
  • Doxorubicin / analogs & derivatives*
  • Doxorubicin / therapeutic use
  • Female
  • Herpesviridae Infections / diagnosis
  • Herpesviridae Infections / pathology
  • Herpesviridae Infections / transmission*
  • Herpesviridae Infections / virology
  • Herpesvirus 8, Human / isolation & purification
  • Humans
  • Liver / diagnostic imaging
  • Liver / pathology
  • Liver / virology
  • Liver Neoplasms / diagnosis
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / pathology
  • Liver Neoplasms / virology
  • Liver Transplantation / adverse effects*
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Polyethylene Glycols / therapeutic use
  • Sarcoma, Kaposi / diagnosis
  • Sarcoma, Kaposi / drug therapy*
  • Sarcoma, Kaposi / pathology
  • Sarcoma, Kaposi / virology
  • Tissue Donors
  • Transplantation, Homologous / adverse effects
  • Treatment Outcome
  • Young Adult

Substances

  • liposomal doxorubicin
  • Polyethylene Glycols
  • Doxorubicin